My Quote Request
No products added yet
6505-01-565-8399
20 Products
NDC11704-0270-01
ANTIDOTE TREATMENT KIT,CYANIDE
NSN, MFG P/N
6505015658399
NSN
6505-01-565-8399
NDC11704-0270-01
ANTIDOTE TREATMENT KIT,CYANIDE
NSN, MFG P/N
6505015658399
NSN
6505-01-565-8399
MFG
MERIDIAN MEDICAL TECHNOLOGIES INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIDOTE TREATMENT KIT CYANIDE HYDROXOCOBALAMIN FOR INJECTION
PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
SPECIAL FEATURES: CONSISTS OF TWO 250 ML GLASS VIALS CONTAINING LYOPHILIZED HYDROXOCOBALAMIN FOR INJECTION; EACH VIAL CONTAINS 2.5 G DARK RED CRYSTALLIZED HYDROXOCOBALAMIN, FOR A TOTAL OF 5 G; MUST BE RECONSTITUTED W/ 100 ML OF DILUENT (NOT PROVIDED); KIT ALSO INCLUDES: 1
USAGE DESIGN: USED AS ANTIDOTE TREATMENT OF KNOWN OR SUSPECTED CYANIDE POISONING
~1: FUSION SET, 2 STERILE TRANSFER SPIKES, AND 1 QUICK REFERENCE GUIDE; STORAGE REQUIREMENTS: ONCE RECONSTITUTED REMAINS STABLE FOR UP TO 6 HRS AT TEMP. NOT TO EXCEED 40 DEG C (104 DEG F) STORE AT 25 C (77 F) ESCURSIONS PERMITTED (59-86 F)
Related Searches:
CYANO KIT
ANTIDOTE TREATMENT KIT,CYANIDE
NSN, MFG P/N
6505015658399
NSN
6505-01-565-8399
CYANO KIT
ANTIDOTE TREATMENT KIT,CYANIDE
NSN, MFG P/N
6505015658399
NSN
6505-01-565-8399
MFG
MERIDIAN MEDICAL TECHNOLOGIES INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIDOTE TREATMENT KIT CYANIDE HYDROXOCOBALAMIN FOR INJECTION
PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
SPECIAL FEATURES: CONSISTS OF TWO 250 ML GLASS VIALS CONTAINING LYOPHILIZED HYDROXOCOBALAMIN FOR INJECTION; EACH VIAL CONTAINS 2.5 G DARK RED CRYSTALLIZED HYDROXOCOBALAMIN, FOR A TOTAL OF 5 G; MUST BE RECONSTITUTED W/ 100 ML OF DILUENT (NOT PROVIDED); KIT ALSO INCLUDES: 1
USAGE DESIGN: USED AS ANTIDOTE TREATMENT OF KNOWN OR SUSPECTED CYANIDE POISONING
~1: FUSION SET, 2 STERILE TRANSFER SPIKES, AND 1 QUICK REFERENCE GUIDE; STORAGE REQUIREMENTS: ONCE RECONSTITUTED REMAINS STABLE FOR UP TO 6 HRS AT TEMP. NOT TO EXCEED 40 DEG C (104 DEG F) STORE AT 25 C (77 F) ESCURSIONS PERMITTED (59-86 F)
Related Searches:
AVASTIN 25MG/ML 4ML
BEVACIZUMAB
NSN, MFG P/N
6505015667532
NSN
6505-01-566-7532
MFG
GENENTECH INC.
Description
SPECIAL FEATURES: DESIGNED TO INHIBIT ANGIOGENESIS,THE PROCESS BY WHICH NEW BLOOD VESSELS DEVELOP AND CARRY VITAL NUTRIENTS TO A TUMOR;SINGLE USE GLASS VIAL TO DELIVER 100 MG PER VIAL;MUST BE REFRIGERATED AT 2-8DEG C(36-46DEG F) AND PROTECTED FROM LIGHT
Related Searches:
AVASTIN 25MG/ML 16ML
BEVACIZUMAB
NSN, MFG P/N
6505015667534
NSN
6505-01-566-7534
MFG
GENENTECH INC.
Description
SPECIAL FEATURES: DESIGNED TO INHIBIT ANGIOGENESIS,THE PROCESS BY WHICH NEW BLOOD VESSELS DEVELOP AND CARRY VITAL NUTRIENTS TO A TUMOR;SINGLE USE GLASS VIAL TO DELIVER 400 MG PER VIAL;MUST BE REFRIGERATED AT 2-8DEG C(36-46DEG F) AND PROTECTED FROM LIGHT
Related Searches:
9435
JAPANESE ENCEPHALITIS VACCINE
NSN, MFG P/N
6505015668993
NSN
6505-01-566-8993
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: JAPANESE ENCEPHALITIS VIRUS VACCINE 2S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
IMMEDIATE CONTAINER QUANTITY: 2
IMMEDIATE CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PURIFIED; INACTIVATED;SUSPENSION FOR INJECTION:CONTAINS 6 MCG PER 0.5ML IN PREFILLED SYRINGE W/PLUNGER STOPPER; PRESERVATIVE FREE;LATEX FREE; FOR AGES 17 YEARS AND, UP; CONSTANT REFRIGERATION, NO EXCURSIONS PERMITTED.
Related Searches:
IC51
JAPANESE ENCEPHALITIS VACCINE
NSN, MFG P/N
6505015668993
NSN
6505-01-566-8993
MFG
INTERCELL GLOBAL LLC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: JAPANESE ENCEPHALITIS VIRUS VACCINE 2S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
IMMEDIATE CONTAINER QUANTITY: 2
IMMEDIATE CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PURIFIED; INACTIVATED;SUSPENSION FOR INJECTION:CONTAINS 6 MCG PER 0.5ML IN PREFILLED SYRINGE W/PLUNGER STOPPER; PRESERVATIVE FREE;LATEX FREE; FOR AGES 17 YEARS AND, UP; CONSTANT REFRIGERATION, NO EXCURSIONS PERMITTED.
Related Searches:
IXIARO
JAPANESE ENCEPHALITIS VACCINE
NSN, MFG P/N
6505015668993
NSN
6505-01-566-8993
MFG
NOVARTIS VACCINES AND DIAGNOSTICS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: JAPANESE ENCEPHALITIS VIRUS VACCINE 2S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
IMMEDIATE CONTAINER QUANTITY: 2
IMMEDIATE CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PURIFIED; INACTIVATED;SUSPENSION FOR INJECTION:CONTAINS 6 MCG PER 0.5ML IN PREFILLED SYRINGE W/PLUNGER STOPPER; PRESERVATIVE FREE;LATEX FREE; FOR AGES 17 YEARS AND, UP; CONSTANT REFRIGERATION, NO EXCURSIONS PERMITTED.
Related Searches:
NCM082857
JAPANESE ENCEPHALITIS VACCINE
NSN, MFG P/N
6505015668993
NSN
6505-01-566-8993
NCM082857
JAPANESE ENCEPHALITIS VACCINE
NSN, MFG P/N
6505015668993
NSN
6505-01-566-8993
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: JAPANESE ENCEPHALITIS VIRUS VACCINE 2S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
IMMEDIATE CONTAINER QUANTITY: 2
IMMEDIATE CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PURIFIED; INACTIVATED;SUSPENSION FOR INJECTION:CONTAINS 6 MCG PER 0.5ML IN PREFILLED SYRINGE W/PLUNGER STOPPER; PRESERVATIVE FREE;LATEX FREE; FOR AGES 17 YEARS AND, UP; CONSTANT REFRIGERATION, NO EXCURSIONS PERMITTED.
Related Searches:
NDC42515-0001-01
JAPANESE ENCEPHALITIS VACCINE
NSN, MFG P/N
6505015668993
NSN
6505-01-566-8993
NDC42515-0001-01
JAPANESE ENCEPHALITIS VACCINE
NSN, MFG P/N
6505015668993
NSN
6505-01-566-8993
MFG
NOVARTIS VACCINES AND DIAGNOSTICS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: JAPANESE ENCEPHALITIS VIRUS VACCINE 2S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
IMMEDIATE CONTAINER QUANTITY: 2
IMMEDIATE CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PURIFIED; INACTIVATED;SUSPENSION FOR INJECTION:CONTAINS 6 MCG PER 0.5ML IN PREFILLED SYRINGE W/PLUNGER STOPPER; PRESERVATIVE FREE;LATEX FREE; FOR AGES 17 YEARS AND, UP; CONSTANT REFRIGERATION, NO EXCURSIONS PERMITTED.
Related Searches:
N2511
ALPHA-1-PROTEINASE INHIBITOR,HUMAN,STERILE
NSN, MFG P/N
6505015669027
NSN
6505-01-566-9027
N2511
ALPHA-1-PROTEINASE INHIBITOR,HUMAN,STERILE
NSN, MFG P/N
6505015669027
NSN
6505-01-566-9027
MFG
PROMEGA CORPORATION
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RNASIN RIBUNUCLEASE INHIBITOR
SPECIAL FEATURES: NATURAL AND RECOMBINANT RNASIN RIBONUCLEASE INHIBITORS HAVE BROAD SPECTRUM RNASE INHIBITORY PROPERTIES INCLUDING THE INHIBITION OF EUKARYOTIC RNASES OF THE NEUTRAL TYPE 1
Related Searches:
6505NCM082804
ALFUZOSIN HYDROCHLO
NSN, MFG P/N
6505015669383
NSN
6505-01-566-9383
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: DO NOT CHEW OR CRUSH TABLET
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALFUZOSIN HCL UROXATRAL EX-RELEASE 10MG BT 100TT
SPECIAL FEATURES: 10MG ACTIVE INGREDIENT, BOTTLE OF 100"S; TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AND RENAL CALCULI; STORE AT CONTROLLED RM TEMP; PROTECT FROM LIGHT AND MOISTURE; TAKE ONE DAILY AFTER THE SAME MEAL
Related Searches:
9083
ALFUZOSIN HYDROCHLO
NSN, MFG P/N
6505015669383
NSN
6505-01-566-9383
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: DO NOT CHEW OR CRUSH TABLET
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALFUZOSIN HCL UROXATRAL EX-RELEASE 10MG BT 100TT
SPECIAL FEATURES: 10MG ACTIVE INGREDIENT, BOTTLE OF 100"S; TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AND RENAL CALCULI; STORE AT CONTROLLED RM TEMP; PROTECT FROM LIGHT AND MOISTURE; TAKE ONE DAILY AFTER THE SAME MEAL
Related Searches:
NDC00024-4200-10
ALFUZOSIN HYDROCHLO
NSN, MFG P/N
6505015669383
NSN
6505-01-566-9383
MFG
SANOFI-AVENTIS U.S. INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: DO NOT CHEW OR CRUSH TABLET
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALFUZOSIN HCL UROXATRAL EX-RELEASE 10MG BT 100TT
SPECIAL FEATURES: 10MG ACTIVE INGREDIENT, BOTTLE OF 100"S; TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AND RENAL CALCULI; STORE AT CONTROLLED RM TEMP; PROTECT FROM LIGHT AND MOISTURE; TAKE ONE DAILY AFTER THE SAME MEAL
Related Searches:
UROXARTAL
ALFUZOSIN HYDROCHLO
NSN, MFG P/N
6505015669383
NSN
6505-01-566-9383
MFG
SANOFI-AVENTIS U.S. INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: DO NOT CHEW OR CRUSH TABLET
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALFUZOSIN HCL UROXATRAL EX-RELEASE 10MG BT 100TT
SPECIAL FEATURES: 10MG ACTIVE INGREDIENT, BOTTLE OF 100"S; TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AND RENAL CALCULI; STORE AT CONTROLLED RM TEMP; PROTECT FROM LIGHT AND MOISTURE; TAKE ONE DAILY AFTER THE SAME MEAL
Related Searches:
6505NCM082841
CHLORHEXIDINE GLUCO
NSN, MFG P/N
6505015672739
NSN
6505-01-567-2739
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORHEXIDINE CLUCONATE ETHYL ALCOHOL CLEANSING SOLUTION 0.34FL OZ 40S
III UNIT PACKAGE QUANTITY: 40
SPECIAL FEATURES: 1%CHLORHEXIDINE GLUCONATE AND 61% ETHYL ALCOHOL 0.34FL OZ. BOTTLES; INCLUDES MOISTURIZERS, WATERLESS AND SCRUBLESS; FOR USE BY SURGICAL AND HEALTHCARE PERSONNEL; PKG/40
Related Searches:
9210
CHLORHEXIDINE GLUCO
NSN, MFG P/N
6505015672739
NSN
6505-01-567-2739
MFG
3M HEALTHCARE PRODUCTS/SALES
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORHEXIDINE CLUCONATE ETHYL ALCOHOL CLEANSING SOLUTION 0.34FL OZ 40S
III UNIT PACKAGE QUANTITY: 40
SPECIAL FEATURES: 1%CHLORHEXIDINE GLUCONATE AND 61% ETHYL ALCOHOL 0.34FL OZ. BOTTLES; INCLUDES MOISTURIZERS, WATERLESS AND SCRUBLESS; FOR USE BY SURGICAL AND HEALTHCARE PERSONNEL; PKG/40
Related Searches:
9283
CHLORHEXIDINE GLUCO
NSN, MFG P/N
6505015672739
NSN
6505-01-567-2739
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORHEXIDINE CLUCONATE ETHYL ALCOHOL CLEANSING SOLUTION 0.34FL OZ 40S
III UNIT PACKAGE QUANTITY: 40
SPECIAL FEATURES: 1%CHLORHEXIDINE GLUCONATE AND 61% ETHYL ALCOHOL 0.34FL OZ. BOTTLES; INCLUDES MOISTURIZERS, WATERLESS AND SCRUBLESS; FOR USE BY SURGICAL AND HEALTHCARE PERSONNEL; PKG/40
Related Searches:
AVAGARD
CHLORHEXIDINE GLUCO
NSN, MFG P/N
6505015672739
NSN
6505-01-567-2739
MFG
3M HEALTHCARE PRODUCTS/SALES
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORHEXIDINE CLUCONATE ETHYL ALCOHOL CLEANSING SOLUTION 0.34FL OZ 40S
III UNIT PACKAGE QUANTITY: 40
SPECIAL FEATURES: 1%CHLORHEXIDINE GLUCONATE AND 61% ETHYL ALCOHOL 0.34FL OZ. BOTTLES; INCLUDES MOISTURIZERS, WATERLESS AND SCRUBLESS; FOR USE BY SURGICAL AND HEALTHCARE PERSONNEL; PKG/40
Related Searches:
EK-057-23
IMMUNOASSAY KIT,APE
NSN, MFG P/N
6505015674122
NSN
6505-01-567-4122
MFG
PHOENIX PHARMACEUTICALS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: APELIN-12 EIA KIT
SPECIAL FEATURES: 96 WELLS; SAMPLES BLOOD, PLASMA EXTRACTION; TISSUE EXTRACTION AND CSF EXTRACTION; MINIMUM DETECTABLE CONCENTRATION IS 0.07 NG/ML; 0-100 NG/ML RANGE; 0.07-0.79 NG/ML LINEAR RANGE
Related Searches:
6505NCM082796
EPINEPHRINE INJECTION,USP
NSN, MFG P/N
6505015674685
NSN
6505-01-567-4685
6505NCM082796
EPINEPHRINE INJECTION,USP
NSN, MFG P/N
6505015674685
NSN
6505-01-567-4685
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS EPINEPHRINE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: EPINEPHRINE INJECTION 1MG PER ML 30ML VIAL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: FOR CORPORATE EXIGENCY CONTRACT
TOTAL PRIMARY CONTAINER QUANTITY: 10
